BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences: Cowen 42nd Annual Health Care Conference Date: Monday… […]
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 /PRNewswire/ — Sutro Biopharma, Inc. ("Sutro" or the "Company") (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise… […]
SAN FRANCISCO, Feb. 28, 2022 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2021. Cash and investments in marketable securities at December 31, 2021 were appro… […]
NEWARK, Calif., Feb. 28, 2022 /PRNewswire/ — Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a corp… […]
PALO ALTO, Calif.–(BUSINESS WIRE)–Endpoint Health, Inc., a precision-firstTM therapeutics company dedicated to addressing urgent needs in immune-driven critical and chronic illnesses, today announced findings from retrospective analyses published in … […]
BERKELEY, Calif. and AMSTERDAM, Feb. 28, 2022 /PRNewswire/ — Actym Therapeutics, a biotechnology company focused on the discovery and development of novel therapies intended to transform the treatment of cancer, and Wacker Biotech announced today that… […]
SAN FRANCISCO, Feb. 28, 2022 /PRNewswire/ — The National AIDS Memorial is honoring the legacy of AIDS educator and activist Pedro Zamora on what would have been his 50th birthday by formally announcing the latest recipients of the Pedro Zamora Young L… […]
Alice Lin Fabiano Amid the surge of environmental, social and governance (ESG) investing, Johnson & Johnson decided to look at where the money was going. It specifically researched impact investing — that is, funding to help a group complete a proj… […]
LOS ANGELES & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Phase 1 trial data showing use of live biotherapeutic CBM588 and immunotherapy medicine can improve survival in patients with metastatic kidney cancer […]
SAN FRANCISCO–(BUSINESS WIRE)–Serotiny, a leader in high-throughput therapeutic Multi-Domain Protein (tMDP) engineering, and Tessera Therapeutics, a biotechnology company pioneering a new approach in genetic medicines known as Gene Writing technology… […]
Copyright © 2022 Biotech Networks, LLC
